Mining key circadian biomarkers for major depressive disorder by integrating bioinformatics and machine learning DOI Creative Commons

Yuhe Shi,

Jue Zhu,

Chaowen Hou

и другие.

Aging, Год журнала: 2024, Номер 16(12), С. 10299 - 10320

Опубликована: Июнь 13, 2024

This study aimed to identify key clock genes closely associated with major depressive disorder (MDD) using bioinformatics and machine learning approaches.

Язык: Английский

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle DOI
Hayder M. Al‐kuraishy, Majid S. Jabir,

Ali K. Albuhadily

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 95, С. 102233 - 102233

Опубликована: Фев. 14, 2024

Язык: Английский

Процитировано

17

Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus DOI Creative Commons
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed

и другие.

Neuropsychopharmacology Reports, Год журнала: 2025, Номер 45(1)

Опубликована: Янв. 5, 2025

Alzheimer's disease (AD) is the most common neurodegenerative associated with development of dementia. The hallmarks AD neuropathology are accumulations amyloid peptide (Aβ) and neurofibrillary tangles (NFTs). Aβ derived from processing APP (amyloid beta precursor protein) by BACE1 (beta-secretase 1) γ-secretase through an amyloidogenic pathway. However, ADAM10/α-secretase (ADAM metallopeptidase domain 10) enzymes a non-amyloidogenic pathway produces soluble alpha (sAPPα), which has neuroprotective effect. It been shown that activated platelets implicated in pathogenesis AD, also increases platelet activation. Under physiological conditions, regulate synaptic plasticity increase neuronal differentiation regulation inflammatory response. overactivated contribute to AD. Activated represent main source circulating may be involved neuropathology. Therefore, there close relationship between platelets. This review discusses potential role how targeting reduce

Язык: Английский

Процитировано

3

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases DOI Creative Commons
Leilei Chen, Qingqing Shen, Yingjuan Liu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2025, Номер 10(1)

Опубликована: Фев. 2, 2025

Язык: Английский

Процитировано

3

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas DOI Creative Commons
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed

и другие.

Frontiers in Medicine, Год журнала: 2025, Номер 12

Опубликована: Фев. 4, 2025

Alzheimer’s disease (AD) is the most common cause of dementia and represents 75% all types. AD neuropathology due to progressive deposition extracellular amyloid-beta (A β ) peptide intracellular hyperphosphorylated tau protein. The accumulated Aβ forms amyloid plaques, while protein neurofibrillary tangles (NFTs). Both plaques NFTs are hallmarks neuropathology. fundamental mechanism involved in pathogenesis still elusive, although more conceivable theory. Aβ-induced neurodegeneration associated neuroinflammation, oxidative stress, endoplasmic reticulum stress (ER), mitochondrial dysfunction contribute development cognitive impairment dementia. Of note, not only originated from brain but also produced peripherally and, via blood–brain barrier (BBB), can accumulate result AD. It has been shown that cardiometabolic conditions such as obesity, type 2 diabetes (T2D), heart failure (HF) regarded possible risk factors for other types dementia, vascular HF-induced chronic cerebral hypoperfusion, inflammation induce progression Interestingly, a systemic causes which turn affects peripheral organs, including heart. through deranged BBB be transported into circulation heart, leading HF. These findings suggest close relationship between However, exact AD-induced HF fully elucidated. Therefore, this review aims discuss link regarding potential role

Язык: Английский

Процитировано

3

Understanding of Alzheimer's Disease Pathophysiology for Therapeutic Implications of Natural Products as Neuroprotective Agents DOI

Sneh Prabha,

Arunabh Choudhury,

Asimul Islam

и другие.

Ageing Research Reviews, Год журнала: 2025, Номер unknown, С. 102680 - 102680

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

2

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(10)

Опубликована: Май 1, 2024

Parkinson's disease (PD) is a neurodegenerative disorder of the brain and manifested by motor non-motor symptoms because degenerative changes in dopaminergic neurons substantia nigra. PD neuropathology associated with mitochondrial dysfunction, oxidative damage apoptosis. Thus, modulation apoptosis growth factors could be novel boulevard management PD. Brain-derived neurotrophic factor (BDNF) its receptor tropomyosin kinase type B (TrkB) are chiefly involved neuropathology. BDNF promotes survival nigra enhances functional activity striatal neurons. Deficiency TrkB triggers degeneration accumulation α-Syn As well, BDNF/TrkB signalling reduced early phase Targeting specific activators may attenuate this review aimed to discuss potential role against In conclusion, decreased linked severity long-term complications. Activation

Язык: Английский

Процитировано

15

Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue DOI Creative Commons
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Molecular Neurobiology, Год журнала: 2024, Номер 61(9), С. 7092 - 7108

Опубликована: Фев. 17, 2024

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative of the brain due to degeneration dopaminergic neurons in substantia nigra (SN). Glycogen synthase kinase 3 beta (GSK-3β) implicated pathogenesis PD. Therefore, purpose present review was revise mechanistic role GSK-3β PD neuropathology, and how inhibitors affect neuropathology. GSK-3 conserved threonine/serine protein that intricate regulation cellular anabolic catabolic pathways by modulating glycogen synthase. Over-expression also interconnected with development different diseases. However, underlying mechanism neuropathology not fully clarified. induces triggering mitochondrial dysfunction oxidative stress SN. NF-κB NLRP3 inflammasome are activated response dysregulated leading neuronal injury. Higher expression early stages might contribute reduction neuroprotective brain-derived neurotrophic factor (BDNF). Thus, may be effective reducing inflammatory disorders which associated

Язык: Английский

Процитировано

11

Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications DOI Open Access
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(22), С. 11955 - 11955

Опубликована: Ноя. 7, 2024

Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two prevalent conditions that present considerable public health issue in aging populations worldwide. Recent research has proposed a novel conceptualization of AD as "type 3 diabetes", highlighting the critical roles insulin resistance impaired glucose metabolism pathogenesis disease. This article examines implications this association, exploring potential new avenues for treatment preventive strategies AD. Key evidence linking to emphasizes metabolic processes contribute neurodegeneration, including inflammation, oxidative stress, alterations signaling pathways. By framing within context, we can enhance our understanding its etiology, which turn may influence early diagnosis, plans, measures. Understanding manifestation opens up possibility employing therapeutic incorporate lifestyle modifications use antidiabetic medications mitigate cognitive decline. integrated approach improve patient outcomes deepen comprehension intricate relationship between neurodegenerative diseases disorders.

Язык: Английский

Процитировано

11

Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective DOI Creative Commons
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Neuropsychopharmacology Reports, Год журнала: 2024, Номер 44(3), С. 639 - 649

Опубликована: Июль 29, 2024

Abstract Neurodegenerative diseases (NDs) such as Alzheimer disease (AD) and Parkinson (PD) are group of affecting the central nervous system (CNS) characterized by progressive neurodegenerations cognitive impairment. Findings from different studies highlighted beneficial detrimental effects serum uric acid on development progression NDs. Therefore, this mini‐review aims to discuss The neuroprotective effect is mainly related antioxidant which alleviates oxidative stress‐induced neurodegeneration in AD PD. However, long‐term hyperuricemia prompts for Hyperuricemia associated with impairment dementia, gout increases dementia risk. In addition, can cause cerebral vascular injury a risk factor Taken together, relationship between NDs remains conflicting. Hence, preclinical clinical indicated regard.

Язык: Английский

Процитировано

7

Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid β1–42 peptide aggregation, acetylcholinesterase and carbonic anhydrase-II DOI Creative Commons
Ayesha Tahir,

Bushra Mobeen,

Fahad Hussain

и другие.

RSC Advances, Год журнала: 2024, Номер 14(21), С. 14742 - 14757

Опубликована: Янв. 1, 2024

Pregnenolone-based derivatives have been synthesized to inhibit the protofibril formation in order reduce Aβ 1–42 production and prevent its aggregation.

Язык: Английский

Процитировано

6